IQVIA™ Real-World Insights Bibliography

Validation of safety outcomes in routinely collected data: lessons learned from a multinational post-approval safety study
Author(s): Arena PJ, Huang K, Löfling L, Bahmanyar S, Mo J, Schachterle SE, Nunes AP, Smits E, Juuti R, Hoti F, Korhonen P, Adelborg K, Sundbøll J, Rasmussen TR, Løkke A, Ehrenstein V.
Affiliations(s): "Pfizer Inc., New York, New York, United States of America. Department of Epidemiology, UCLA Fielding School of Public Health, Los Angeles, California, United States of America. EPID Research (an IQVIA company), Espoo, Finland."
Publication(s):  Pharmacoepidemiol Drug Saf. 2022 Dec 10. doi: 10.1002/pds.5582
Document Type(s): Article,
Countries: Denmark, Finland, Netherlands , Sweden, USA,
Click here for the abstract
C:
Y:
Database Validity and methodology, Drug safety, Oncology,
2022
  L:
A:
English
Clinical setting: hospital, Clinical setting: Primary care, clinical setting: Secondary care, Retrospective database analysis,
  Add to report
 
 
An exploratory assessment of the applicability of direct-to-consumer genetic testing to translational research in Japan
Author(s): Masahiro Inoue 1, Shota Arichi 1, Tsuyoshi Hachiya 1, Anna Ohtera 2, Seok-Won Kim 2, Eric Yu 2, Masatoshi Nishimura 3, Kazuhito Shiosakai 3, Takeshi Ohira 3 (rwesheorj 2)
Affiliations(s): 1) HealthData Lab, Yahoo! Japan Corporation, Kioi Tower, Tokyo Garden Terrace Kioicho, 1-3, Kioi-cho, Chiyoda-ku, Tokyo, 102-8282, Japan 2) Real World Evidence Solutions, IQVIA Solutions Japan K.K, Takanawa 4-10-18, Minato-ku, Tokyo, 108-0074, Japan 3) Daiichi Sankyo Co. Ltd, Tokyo, Japan
Publication(s):  BMC Research Notes
Document Type(s): Article,
Countries: Japan,
Click here for the abstract
C:
Y:
Database Validity and methodology,
2021
  L:
A:
English
Methodology, Patient questionnaire, Real World Evidence, Survey research,
  Add to report
 
 
Identification of potentially undiagnosed patients with nontuberculous mycobacterial lung disease using machine learning applied to primary care data in the UK
Author(s): Orla M Doyle 1 2, Roald van der Laan 3 2, Marko Obradovic 4 2, Peter McMahon 5, Flora Daniels 6, Ashley Pitcher 7, Michael R Loebinger 8
Affiliations(s): Predictive Analytics, Real World Analytical Solutions, IQVIA, London, UK. 2These authors contributed equally. 3Insmed Utrecht, Utrecht, The Netherlands. 4Insmed Utrecht, Utrecht, The Netherlands marko.obradovic@insmed.com. 5Real-World Insights, IQVIA, London, UK. 6Real-World Insights, IQVIA, Basel, Switzerland. 7Real-World Insights, IQVIA, Copenhagen, Denmark. 8Royal Brompton and Harefield NHS Foundation Trust and Imperial College London, London, UK.
Publication(s):  PMID: 32430411 DOI: 10.1183/13993003.00045-2020
Document Type(s): Article,
Countries: Switzerland, UK,
Click here for the abstract
C:
Y:
Database Validity and methodology, Pain,
2021
  L:
A:
English
Population Based Study, Real World Evidence, Retrospective database analysis,
  Add to report
 
 
Validation of an ICD-10-based algorithm to identify stillbirth in the Sentinel System
Author(s): Andrade SE, Shinde M, Moore Simas TA, Bird ST, Bohn J, Haynes K, Taylor LG, Lauring JR, Longley E, McMahill-Walraven CN, Trinacty CM, Saphirak C, Delude C, DeLuccia S, Zhang T, Cole DV, DiNunzio N, Gertz A, Fazio-Eynullayeva E, Stojanovic D
Affiliations(s): "1The Meyers Primary Care Institute, a joint endeavor of the University of Massachusetts Medical School, Reliant Medical Group, and Fallon Health, University of Massachusetts Medical School, Worcester, Massachusetts, USA. 2Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, Massachusetts, USA. 3Department of Obstetrics and Gynecology, University of Massachusetts Medical School/UMass Memorial Health Care, Worcester, Massachusetts, USA. 4Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA. / L Taylor - IQVIA - RWS 5Department of Scientific Affairs, HealthCore, Inc., Wilmington, Delaware, USA. 6Community Health Care Family Medicine Residency, Tacoma, Washington, USA. 7CVS Health Clinical Trial Services, Part of the CVS Health Family of Companies, Blue Bell, Pennsylvania, USA. 8Kaiser Permanente Center for Integrated Health Care Research Hawaii and Office of Public Health Studies, University of Hawai'i Manoa, Honolulu, Hawaii, USA."
Publication(s):  "Pharmacoepidemiol Drug Saf. 2021 Sep;30(9):1175-1183. doi: 10.1002/pds.5300. Epub 2021 Jun 11. PMID: 34089206"
Document Type(s): Article,
Countries: USA,
Click here for the abstract
C:
Y:
Database Validity and methodology, Womens Health,
2021
  L:
A:
English
Epidemiological study, Retrospective database analysis,
  Add to report
 
 
Incorporating patient generated health data into pharmacoepidemiological research. Pharmacoepidemiology and Drug Safety.
Author(s): Alison Bourke 1, William G Dixon 2, Andrew Roddam 3, Kueiyu Joshua Lin 4, Gillian C Hall 5, Jeffrey R Curtis 6, Sabine N van der Veer 7, Montse Soriano-Gabarró 8, Juliane K Mills 9, Jacqueline M Major 10, Thomas Verstraeten 11, Matthew J Francis 12, Dorothee B Bartels 13
Affiliations(s): 1Real World Solutions, IQVIA, London, UK. 2Arthritis Research UK Centre for Epidemiology, The University of Manchester, Manchester, UK. 3Data & Computational Sciences, GSK, London, UK. 4Brigham and Women's & Department of Medicine, Boston, Massachusetts, USA. 5Gillian Hall Epidemiology Ltd, London, UK. 6Division of Clinical Immunology & Rheumatology, The University of Birmingham, Birmingham, Alabama, USA. 7Centre for Health Informatics, Division of Informatics, Imaging and Data Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK. 8Bayer AG, Berlin, Germany. 9PRA Health Sciences, Raleigh, North Carolina, USA. 10Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA. 11P95 Pharmacovigilance and Epidemiology, Leuven, Belgium. 12The Procter & Gamble Company, Cincinnati, Ohio, USA. 13UCB Pharma, Anderlecht, Belgium.
Publication(s):  Pharmacoepidemiol Drug Saf . 2020 Dec;29(12):1540-1549. doi: 10.1002/pds.5169. Epub 2020 Nov 13.
Document Type(s): Article,
Countries: Belgium, Germany, UK, USA,
Click here for the abstract
C:
Y:
Database Validity and methodology, Health status & patient reported outcomes, Patient Registries & Real-World Study Methods,
2021
  L:
A:
English
Patient questionnaire, Review,
  Add to report
 
 
Ability of primary care health databases to assess medicinal products discussed by the European Union Pharmacovigilance Risk Assessment Committee
Author(s): Robert Flynn1,2,*, Karin Hedenmalm1, Tarita Murray-Thomas3, Alexandra Pacurariu1, Peter Arlett1, Hilary Shepherd3, Puja Myles3, Xavier Kurz1
Affiliations(s): 1 Pharmacovigilance and Epidemiology Department, European Medicines Agency, Amsterdam, The Netherlands 2 Medicines Monitoring Unit (MEMO), Division of Molecular and Clinical Medicine, University of Dundee, Dundee, United Kingdom 3 Clinical Practice Research Datalink (CPRD), MHRA, London, United Kingdom
Publication(s):  First published: 18 January 2020 https://doi.org/10.1002/cpt.1775
Document Type(s): Abstract, Article,
Countries: France, Germany, UK,
Click here for the abstract
C:
Y:
Database Validity and methodology, Drug safety, Health policy,
2020
  L:
A:
English
Retrospective database analysis,
  Add to report
 
 
IQVIA hospital information system DATA secondary use for outcome identification to assess the validity of definitions
Author(s): Masaya H 1, Kenji Hamada 1, Masafumi Okada 1, Dilinuer Ainiwaer 1, Masaaki I 1, Takeshi Akiyama 1 (rwesheorj 1)
Affiliations(s): 1) IQVIA Solutions Japan K.K., Tokyo, Japan
Publication(s):  ISPOR Asia Pacific
Document Type(s): Abstract, Conference, Presentation,
Countries: Japan,
Click here for the abstract
C:
Y:
Database Validity and methodology,
2020
  L:
A:
English
De-identification / anonymisation ,
  Add to report
 
 
Retrospective study for comorbidities in ACTIVE population using Japanese health insurance claims database
Author(s): Seok-Won Kim 1, Ayumi Morishita 1, Takeshi Akiyama 1 (rwesheorj 1)
Affiliations(s): 1) Real World Evidence Solutions, IQVIA Solutions Japan K.K.
Publication(s):  ISPOR Asia Pacific 2020 Conference
Document Type(s): Abstract,
Countries: Japan,
Click here for the abstract
C:
Y:
Database Validity and methodology,
2020
  L:
A:
English
Database Study,
  Add to report
 
 
Development and validation of patient-level prediction models for adverse outcomes following total knee arthroplasty
Author(s): Ross D. Williams, Jenna M. Reps, Anthony G. Sena, Edward Burn, Ying He, Daniel R. Morales, David Culliford, Dahai Yu, Victoria Y. Strauss, Talita Duarte-Salles, Albert Prats-Uribe, Antonella Delmestri, James Weaver, William Sproviero, Danielle Robinson, Henry Morgan Stewart, Belay Birlie, Rafael Pinedo-Villanueva, Spyros Kolovos, Luis H. John, Ruth E. Costello, Michel van Speybroeck, Caroline O’Leary, Evan Minty, Thomas Falconer, Alison Callahan, Stephen Pfohl, Theresa Burkard, Jennifer Lane, Peter R. Rijnbeek, Patrick B. Ryan, Daniel Prieto-Alhambra
Affiliations(s): 1Erasmus University Medical Centre, Rotterdam 2Janssen Research and Development, Raritan, NJ, USA 3NDORMS, University of Oxford, Oxford, UK 4University of Dundee, UK 5NIHR Applied Research Collaboration Wessex, University of Southampton, UK 6Keele University, Keele, UK 7Fundació Institut Universitari per a la recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain 8Department of Psychiatry, University of Oxford, Oxford, UK 9IQVIA, London, UK 10Centre for Epidemiology Versus Arthritis, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK 11Janssen Pharmaceutica, Beerse, Belgium 12O’Brien Institute of Public Health, Faculty of Medicine, University of Calgary, Alberta, Canada 13Department of Biomedical Informatics, Columbia University Medical Center 14Center for Biomedical Informatics Research, School of Medicine, Stanford University, Stanford, California, USA 15University of Basel, Switzerland
Publication(s):  doi: https://doi.org/10.1101/2020.12.14.20240994
Document Type(s): Abstract,
Countries: UK,
Click here for the abstract
C:
Y:
Database Validity and methodology,
2020
  L:
A:
English
clinical setting: Secondary care, Database Study, direct to patient research, Methodology, Observational study,
  Add to report
 
 
Prescribing Pathways to Triple Therapy: A Retrospective Observational Study of Adults with Chronic Obstructive Pulmonary Disease in the UK
Author(s): Jennifer K Quint 1, Alessandra Venerus 2, Caroline O'Leary 2, Melissa Myland 2, Ulf Holmgren 3, Precil Varghese 4, Claudia Cabrera 3 5
Affiliations(s): 1Imperial College London, London, UK. 2IQVIA, London, UK. 3Real World Science and Digital, BioPharmaceuticals Medical, AstraZeneca, Gothenburg, Sweden. 4Global Medical Affairs, AstraZeneca, Gaithersburg, MD, USA. 5Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden.
Publication(s):  PMID: 33324049 PMCID: PMC7733404 DOI: 10.2147/COPD.S278101
Document Type(s): Article,
Countries: UK,
Click here for the abstract
C:
Y:
Database Validity and methodology,
2020
  L:
A:
English
Observational study, Retrospective database analysis,
  Add to report
 
 
 1 of 7 Next Page Last Page